Literature DB >> 9520175

Profound and unanticipated anemia with lamivudine-zidovudine combination therapy in zidovudine-experienced patients with HIV infection.

E K Hester, J E Peacock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9520175

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  3 in total

1.  Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.

Authors:  Scott Dryden-Peterson; Roger L Shapiro; Michael D Hughes; Kathleen Powis; Anthony Ogwu; Claire Moffat; Sikhulile Moyo; Joseph Makhema; Max Essex; Shahin Lockman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

2.  Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana.

Authors:  Katherine T Steele; Andrew P Steenhoff; Craig W Newcomb; Tumelo Rantleru; Rudo Nthobatsang; Gloria Lesetedi; Scarlett L Bellamy; Jean B Nachega; Robert Gross; Gregory P Bisson
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

3.  A case series of emtricitabine-induced pure red cell aplasia.

Authors:  Nithendra Manickchund; Camille du Plessis; Melanie-Anne A John; Thandekile C Manzini; Bernadett I Gosnell; Mahomed-Yunus S Moosa
Journal:  South Afr J HIV Med       Date:  2021-08-30       Impact factor: 2.744
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.